Clinical trial · Observational
Quality of Life After Cytoreductive Surgery and Intraperitoneal Chemotherapy
Recovery of Quality of Life After Cytoreductive Surgery and Intraperitoneal Chemotherapy for Colorectal Cancer and Pseudomyxoma Peritonei
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): protocol change
Summary
Brief summary (as posted)
Cytoreductive surgery with intraperitoneal chemotherapy is one of the most important treatments for patients with colorectal cancer and peritoneal metastasis. For the best survival rates, complete removal of all metastatic lesions is the most important part of treatment, and various surgical procedures are required for the complete cytoreduction. Therefore, the postoperative morbidity rates are higher than those of localized colon cancer surgeries and patients can experience a prolonged recovery period and deterioration of physical activities over a long period. The aim of this study is to investigate the change of quality of life after cytoreductive surgery and intraperitoneal chemotherapy for colorectal cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Cancer Metastatic | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Cytoreductive surgery and intraperitoneal chemotherapy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Brief pain inventory (BPI)
- timeFrame
- Changes from baseline pain scores at postoperative 12 months
- description
- Pain recovery after cytoreductive surgery and intraperitoneal chemotherapy
Secondary outcomes (7)
- measure
- European Organisation for Research and Treatment of Cancer (EORTC) Quality of life questionnaire (QLQ)-C30
- timeFrame
- preoperative, postoperative 3 months, postoperative 6 months, postoperative 12 months, postoperative 24 months
- description
- Qualify of life questionnaire for cancer patients
- measure
- EORTC QLQ for colorectal cancer
- timeFrame
- preoperative, postoperative 3 months, postoperative 6 months, postoperative 12 months, postoperative 24 months
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Inclusion Criteria: * Colorectal cancer peritoneal metastasis * Pseudomyxoma peritonei * ECOG (Eastern Cooperative Oncology Group) performance status 0-3 * Normal bone marrow, kidney, and liver function * Patient must sign and date the informed consent Exclusion Criteria: * Palliative surgery * Palliative intraperitoneal chemotherapy * Psychotic disorder * Drug abuser
References
Publications (0)
Data not yet available